CODICE |
DESCRIZIONE |
CAS-N |
CONFEZIONE |
|
|
366745000 |
(S)-N-BOC-2-Furylalanine tert-butylamine, 95%, 98% ee |
881690-67- |
500MG |
|
|
361920010 |
(S)-N-BOC-4-Fluorophenylglycine, 95%, 98% ee |
142186-36- |
1GR |
|
|
361780010 |
(S)-N-BOC-4-Thiazoylalanine, 95%, 98% ee |
119434-75- |
1GR |
|
|
390100010 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
1GR |
|
|
390100050 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
5GR |
|
|
390105000 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
500MG |
|
|
390100010 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
1GR |
|
|
390100050 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
5GR |
|
|
390105000 |
(S)-N-BOC-Allylglycine, 95% |
90600-20-7 |
500MG |
|
|
441160010 |
(S)-N-BOC-alpha-Allylglycine dicyclohexylamine salt, 98%, 98% ee |
143979-15- |
1GR |
|
|
441131000 |
(S)-N-BOC-alpha-Ethylalanine, 98%, 98% ee |
151171-11- |
100MG |
|
|
441135000 |
(S)-N-BOC-alpha-Ethylalanine, 98%, 98% ee |
151171-11- |
500MG |
|
|
397830010 |
(S)-N-BOC-Piperidine-2-carboxylic acid, 98% |
26250-84-0 |
1GR |
|
|
397830050 |
(S)-N-BOC-Piperidine-2-carboxylic acid, 98% |
26250-84-0 |
5GR |
|
|
397830250 |
(S)-N-BOC-Piperidine-2-carboxylic acid, 98% |
26250-84-0 |
25GR |
|
|
368290010 |
(S)-N-BOC-Prolinal, 97% |
69610-41-9 |
1GR |
|
|
368290050 |
(S)-N-BOC-Prolinal, 97% |
69610-41-9 |
5GR |
|
|
368290250 |
(S)-N-BOC-Prolinal, 97% |
69610-41-9 |
25GR |
|
|
361800010 |
(S)-N-BOC-Propargylglycine, 95%, 98% ee |
63039-48-5 |
1GR |
|
|
361805000 |
(S)-N-BOC-Propargylglycine, 95%, 98% ee |
63039-48-5 |
500MG |
|
|
441091000 |
(S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine, 98%, 98% ee |
1172127-44 |
100MG |
|
|
441095000 |
(S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine, 98%, 98% ee |
1172127-44 |
500MG |
|
|
441081000 |
(S)-N-FMOC-alpha-Methylphenylalanine sesquihydrate, 98%, 98% ee |
135944-05- |
100MG |
|
|
441151000 |
(S)-N-FMOC-alpha-Methylvaline, 98%, 98% ee |
169566-81- |
100MG |
|
|
441155000 |
(S)-N-FMOC-alpha-Methylvaline, 98%, 98% ee |
169566-81- |
500MG |
|
|
361600010 |
(S)-N-FMOC-Azetidine-2-carboxylic acid, 95%, 98% ee |
136552-06- |
1GR |
|
|
361605000 |
(S)-N-FMOC-Azetidine-2-carboxylic acid, 95%, 98% ee |
136552-06- |
500MG |
|
|
361490010 |
(S)-N-FMOC-Octylglycine, 95%, 98% ee |
193885-59- |
1GR |
|
|
337810010 |
(S)-Phenyl superquat, 98% |
168297-84- |
1GR |
|
|
449450050 |
(S)-Styrene oxide, 94% |
20780-54-5 |
5GR |
|
|
449450250 |
(S)-Styrene oxide, 94% |
20780-54-5 |
25GR |
|
|
391080010 |
(S)-tert-Butylsulfinamide, 97+%, (>98.0% ee) |
343338-28- |
1GR |
|
|
391080050 |
(S)-tert-Butylsulfinamide, 97+%, (>98.0% ee) |
343338-28- |
5GR |
|
|
377530010 |
(S)-tert-Leucinol, 95% |
112245-13- |
1GR |
|
|
377530050 |
(S)-tert-Leucinol, 95% |
112245-13- |
5GR |
|
|
377532500 |
(S)-tert-Leucinol, 95% |
112245-13- |
250MG |
|
|
293460010 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
1GR |
|
|
293460050 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
5GR |
|
|
293462500 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
250MG |
|
|
293460010 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
1GR |
|
|
293460050 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
5GR |
|
|
293462500 |
(S,S)-(+)-2,5-Bis(methoxymethyl)pyrrolidine, 96% |
93621-94-4 |
250MG |
|
|
437281000 |
(S,S)-[2-(4'-Isopropyloxazolin-2'yl)ferrocenyl]diphenylphosphine, 97% |
163169-29- |
100MG |
|
|
437282500 |
(S,S)-[2-(4'-Isopropyloxazolin-2'yl)ferrocenyl]diphenylphosphine, 97% |
163169-29- |
250MG |
|
|
370620010 |
(tert-Butoxycarbonylmethylene)triphenylphosphorane, 97% |
35000-38-5 |
1GR |
|
|
370620050 |
(tert-Butoxycarbonylmethylene)triphenylphosphorane, 97% |
35000-38-5 |
5GR |
|
|
370620250 |
(tert-Butoxycarbonylmethylene)triphenylphosphorane, 97% |
35000-38-5 |
25GR |
|
|
397510010 |
(tert-Butyldimethylsiloxy)acetaldehyde, 90% |
102191-92- |
1GR |
|
|
397510050 |
(tert-Butyldimethylsiloxy)acetaldehyde, 90% |
102191-92- |
5GR |
|
|
381300010 |
(tert-Butyldimethylsilyl)acetylene, 97% |
86318-61-8 |
1GR |
|
|